686758-01-0

Basic information

• Product Name: 1,4-Benzodioxin-2-Methanol, 6-aMino-2,3-dihydro-
• Synonyms: 1,4-Benzodioxin-2-Methanol, 6-aMino-2,3-dihydro-;(6-aMino-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)Methanol
• CAS NO: 686758-01-0
• Molecular Formula: C₉H₁₁NO₃
• Molecular Weight: 181.18854
• Mol File: 686758-01-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,4-Benzodioxin-2-Methanol, 6-aMino-2,3-dihydro-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Benzodioxin-2-Methanol, 6-aMino-2,3-dihydro-(686758-01-0)
• EPA Substance Registry System: 1,4-Benzodioxin-2-Methanol, 6-aMino-2,3-dihydro-(686758-01-0)

Safety Data

• Hazardous Substances Data: 686758-01-0(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

The compound has a benzene ring (a six-membered ring with alternating single and double bonds) fused to a 1,4-dioxane ring (a six-membered ring with two oxygen atoms at the 1st and 4th positions).

Explanation

A hydroxyl group (-OH) is present in the compound, which is attached to one of the carbon atoms in the benzene ring.

Explanation

The compound contains an amino group (-NH2) attached to the 6th carbon atom of the benzene ring.

Explanation

A dihydrofuran ring (a five-membered ring with one double bond and two hydrogen atoms) is present at the 2nd and 3rd positions of the benzene ring.
6. Derivative of 1,4-benzodioxane

Explanation

The compound is derived from 1,4-benzodioxane, which is a benzene ring fused with a dioxane ring.

Explanation

Due to its unique structure and potential pharmacological properties, the compound may be used in the development of new organic compounds and pharmaceuticals.

Explanation

The compound may serve as a starting material or intermediate in the synthesis of various other organic compounds, due to its versatile structure and functional groups.

Structure

Benzene ring fused with a 1,4-dioxane ring

Hydroxyl group

Attached to the benzene ring

Amino group

At the 6th position

Dihydrofuran ring

At the 2nd and 3rd positions

Potential applications

Organic synthesis and pharmaceutical research

Precursor or intermediate

In the synthesis of other organic compounds

Upstream product

• 2271-72-9 (6-nitro-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol 

Downstream Products

• 686756-87-6 3-(2-bromo-phenyl)-7-(2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-ylamino)-1-methyl-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one 

Relevant articles and documents

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives

Compounds of formula I are described. These compounds are protein kinase inhibitors, in particular they inhibit the src family tyrosine kinases. Thus, these compounds are useful for the treatment of diseases mediated by src tyrosine kinases, including cel